MK

Mitul Khodabhai Bhayani

Active Director Additional Director DIN 11384416
DIN 11384416 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value •••• Premium profile

About Mitul Khodabhai Bhayani

Data last updated:

Mitul Khodabhai Bhayani is an Additional Director at Ami Drugs Private Limited (since 2025). The company operates in Pharma. Ami Drugs Private Limited reported revenue of ₹1.1 Lakh (FY 2019).

DIN 11384416
Primary Designation Additional Director
Industry Pharma
First Appointment 17 Nov 2025
Oldest Company Age 15 yrs
Largest company Ami Drugs Private Limited · ₹1.1 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ami Drugs Private Limited U21001GJ2011PTC063805
Additional Director17 Nov 20252011₹1.1 Lakh (FY 2019)Active

Directorship timeline

Open interactive timeline →
Ami Drugs Private Limited
Premium access

Shareholding and investment profile for Mitul Khodabhai Bhayani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mitul Khodabhai Bhayani

Mitul Khodabhai Bhayani currently holds 1 directorship: Ami Drugs Private Limited (Additional Director, since 17 Nov 2025, revenue ₹1.1 Lakh (FY 2019)).

Mitul Khodabhai Bhayani was first appointed on 17 Nov 2025 as Additional Director at Ami Drugs Private Limited.

The current boards of Mitul Khodabhai Bhayani's companies include Akshay Rajeshbhai Boghara (Ami Drugs Private Limited), Ameeshi Girishkumar Chovatia (Ami Drugs Private Limited), Girishkumar Limbabhai Chovatia (Ami Drugs Private Limited), Kiranben Girishbhai Chovatia (Ami Drugs Private Limited), Neetaben Bharatkumar Boghara (Ami Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available